Table 2 Percentage of pharmaceuticals in each pathway calculated with emission model of this study
From: An emission model tracking the life cycle pathways of human pharmaceuticals in Korea
Pharmaceuticals | INCN.in | LEACH.in | NISO.in | STP.in | TE.water |
|---|---|---|---|---|---|
Acetaminophen | 16.9 | 4.5 | 3.4 | 5.1 | 1.1 |
Acetylsalicylic acid | 16.9 | 4.3 | 21.7 | 30.0 | 4.2 |
Amoxicillin | 16.8 | 4.3 | 32.8 | 45.1 | 15.6 |
Ampicillin | 16.8 | 4.4 | 21.4 | 29.6 | 10.9 |
Cefaclor | 17.0 | 4.4 | 36.5 | 50.1 | 17.1 |
Cefadroxil | 17.0 | 4.5 | 48.0 | 65.8 | 22.0 |
Cefatrizine | 17.0 | 4.4 | 25.0 | 34.4 | 12.3 |
Cephradine | 16.9 | 4.6 | 48.0 | 65.7 | 22.1 |
Cimetidine | 16.8 | 4.4 | 31.0 | 42.4 | 14.7 |
Ciprofloxacin | 16.9 | 4.4 | 26.5 | 36.6 | 24.2 |
Diclofenac | 16.8 | 4.4 | 25.2 | 34.0 | 11.8 |
Erythromycin | 16.9 | 4.3 | 1.6 | 2.7 | 6.8 |
Ibuprofen | 16.9 | 4.4 | 0.6 | 1.1 | 0.6 |
Lincomycin | 16.8 | 4.5 | 4.3 | 6.4 | 3.4 |
Mefenamic acid | 16.9 | 4.6 | 4.9 | 6.8 | 3.4 |
Naproxen | 17.0 | 4.5 | 0.6 | 1.1 | 0.6 |
Roxithromycin | 16.9 | 4.5 | 24.8 | 34.3 | 40.3 |
Streptomycin | 16.7 | 4.4 | 29.6 | 40.7 | 14.3 |
Trimethoprim | 16.9 | 4.5 | 31.9 | 43.7 | 28.1 |